platform
A platform approach to animal-free 3D assays.
The REVOLV architecture is engineered around a singular objective: functional 3D tissue models must become faster to produce, simpler to standardize, and entirely compatible with automated industrial workflows.
By unifying tomographic light fabrication, algorithmic calibration, and advanced material science, REVOLV transitions volumetric bioprinting from an elite research capability into a robust, high-throughput manufacturing standard.
Core Engineering Tracks
Technical architecture stack.
Track 01
Light-based printing system
Track 02
AI-guided print control
Track 03
Dynamic animal-free bioresins
hardware
REVOLV uses patterned light to shape cell-containing bioresin inside a rotating vial. The full 3D structure forms at once, without direct contact. The system is designed to create 5 mm-class constructs directly.
Published Science: Bernal et al., Volumetric Bioprinting of Complex Living-Tissue Constructs Within Seconds, Advanced Materials (2019).
Biological Interior Map
Architectural & biological relevance
REVOLV moves beyond static, single-material scaffolds or simple spheroids to deliver tissue models with genuine biological utility
Multicellular complexity
The platform simultaneously accommodates multiple cell lineages. In our liver validation case, this includes three distinct human lineages—endothelial cells, hepatocytes, and pericytes.
Organoid compatibility
The exceptionally gentle, low-shear volumetric process safely embeds highly sensitive, patient-derived liver organoids within the printed architecture without sacrificing cell viability.
Perfusable microstructures
Internal channels are built directly into the design, allowing for continuous media exchange and fluid flow to mimic natural vasculature and support long-term functional tissue behavior.
Technical Enquiry
Fast printing. Functional validation.
The deeper value of REVOLV is the consistency, automated format, and GMP-aligned quality logic required for global pharmaceutical adoption.